KLING DOUGLAS F (Chief Operating Officer) sold 69.4% of their position (100K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Insider sale on the open market — a major position exit. Check remaining position size for full context.
S · 2 sales
Filed: 2/20/2025ACC: 0000950170-25-024322
Officer· Chief Operating Officer
Since Dec 2023
-100K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
6
Total transactions
100K acquired · 200K disposed
Non-Derivative Transactions4
Ordinary Shares
Direct
Shares
+90.78K
Price / share
—
Trade value
—
% of position
206.3%
2/18/2025
44K→134.78K
Ordinary Shares
Direct
Shares
−90.78K
Price / share
—
Trade value
—
% of position
67.4%
2/18/2025
134.78K→44K
Ordinary Shares
Direct
Shares
+9.22K
Price / share
—
Trade value
—
% of position
20.9%
2/19/2025
44K→53.22K
Ordinary Shares
Direct
Shares
−9.22K
Price / share
—
Trade value
—
% of position
17.3%
2/19/2025
53.22K→44K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/18/2025 | M · Option Exercise | +90.78K | — | — | 206.3% | 44K | 134.78K |
| Ordinary Shares Direct | 2/18/2025 | S · Sale | −90.78K | — | — | 67.4% | 134.78K | 44K |
| Ordinary Shares Direct | 2/19/2025 | M · Option Exercise | +9.22K | — | — | 20.9% | 44K | 53.22K |
| Ordinary Shares Direct | 2/19/2025 | S · Sale | −9.22K | — | — | 17.3% | 53.22K | 44K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions2
Option (right to buy)
Direct
Converts to
Ordinary Shares
90.78K shares
Shares
−90.78K
Strike price
Held after
135.36K
Exercisable
—
2/18/2025
Option (right to buy)
Direct
Converts to
Ordinary Shares
9.22K shares
Shares
−9.22K
Strike price
Held after
126.14K
Exercisable
—
2/19/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares90.78K shares | 2/18/2025 | M · Option Exercise | −90.78K | — | 135.36K | |
| Option (right to buy) Direct | Ordinary Shares9.22K shares | 2/19/2025 | M · Option Exercise | −9.22K | — | 126.14K |